Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis type 3.
BACKGROUND
Mutations of UNC13D are causative for familial haemophagocytic lymphohistiocytosis type 3 (FHL3; OMIM 608898).


OBJECTIVE
To carry out a genotype-phenotype study of patients with FHL3.


METHODS
A consortium of three countries pooled data on presenting features and mutations from individual patients with biallelic UNC13D mutations in a common database.


RESULTS
84 patients with FHL3 (median age 4.1 months) were reported from Florence, Italy (n=54), Hamburg, Germany (n=18), Stockholm, Sweden (n=12). Their ethnic origin was Caucasian (n=57), Turkish (n=10), Asian (n=7), Hispanic (n=4), African (n=3) (not reported (n=3)). Thrombocytopenia was present in 94%, splenomegaly in 96%, fever in 89%. The central nervous system (CNS) was involved in 49/81 (60%) patients versus 36% in patients with FHL2 (p=0.001). A combination of fever, splenomegaly, thrombocytopenia and hyperferritinaemia was present in 71%. CD107a expression, NK activity and Munc 13-4 protein expression were absent or reduced in all but one of the evaluated patients. 54 different mutations were observed, including 15 new ones: 19 missense, 14 deletions or insertions, 12 nonsense, nine splice errors. None was specific for ethnic groups. Patients with two disruptive mutations were younger than patients with two missense mutations (p<0.001), but older than comparable patients with FHL2 (p=0.001).


CONCLUSIONS
UNC13D mutations are scattered over the gene. Ethnic-specific mutations were not identified. CNS involvement is more common than in FHL2; in patients with FHL3 and disruptive mutations, age at diagnosis is significantly higher than in FHL2. The combination of fever, splenomegaly, thrombocytopenia and hyperferritinaemia appears to be the most easily and frequently recognised clinical pattern and their association with defective granule release assay may herald FHL3.
Department of Pediatric Hematology and Oncology, Azienda Ospedaliero-Universitaria Meyer, Florence, Italy.
Elena
E
Sieni
Valentina
V
Cetica
Alessandra
A
Santoro
Karin
K
Beutel
Elena
E
Mastrodicasa
Marie
M
Meeths
Benedetta
B
Ciambotti
Francesca
F
Brugnolo
Udo
U
zur Stadt
Daniela
D
Pende
Lorenzo
L
Moretta
Gillian M
GM
Griffiths
Jan-Inge
JI
Henter
Gritta
G
Janka
Maurizio
M
Aricò
D000293:Adolescent; D017668:Age of Onset; D015550:Cell Degranulation / Q000235:genetics / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D003602:Cytotoxicity, Immunologic / Q000235:genetics / Q000276:immunology; D005260:Female; D023061:Gene Order; D056726:Genetic Association Studies; D005838:Genotype; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007694:Killer Cells, Natural / Q000502:physiology; D051359:Lymphohistiocytosis, Hemophagocytic / Q000235:genetics / Q000276:immunology; D008297:Male; D008565:Membrane Proteins / Q000235:genetics; D009154:Mutation / Q000235:genetics; D010641:Phenotype
D008565:Membrane Proteins; C507969:UNC13D protein, human
Hum Mutat. 2006 Jan;27(1):62-8
16278825
J Med Genet. 2001 Sep;38(9):643-6
11565555
Br J Haematol. 2003 May;121(3):503-10
12716377
Br J Haematol. 2005 Jun;129(5):622-30
15916685
Haematologica. 2010 Apr;95(4):622-6
20015888
Pediatr Blood Cancer. 2007 Feb;48(2):124-31
16937360
Br J Haematol. 2008 Feb;140(3):327-35
18076710
Am J Hum Genet. 1999 Jan;64(1):165-71
9915955
Bone Marrow Transplant. 2008 Aug;42(3):175-80
18454181
Immunol Rev. 2005 Feb;203:165-79
15661029
Arch Dis Child. 1952 Dec;27(136):519-25
13008468
Arch Dis Child. 1988 Mar;63(3):292-6
3355209
Haematologica. 2008 Jul;93(7):1086-90
18492689
Semin Oncol. 1991 Feb;18(1):29-33
1992521
Blood. 2006 Oct 1;108(7):2316-23
16778144
Blood. 1997 Dec 15;90(12):4743-8
9389690
Br J Haematol. 2002 Jun;117(4):965-72
12060139
Cell. 2003 Nov 14;115(4):461-73
14622600
J Med Genet. 2008 Jan;45(1):15-21
17873118
Am J Hum Genet. 1999 Jan;64(1):172-9
9915956
Br J Haematol. 2010 Sep;150(6):727-30
20618327
J Clin Invest. 2006 Jan;116(1):182-92
16374518
J Med Genet. 2008 Mar;45(3):134-41
17993578
J Clin Invest. 2009 Dec;119(12):3765-73
19884660
J Med Genet. 2006 Dec;43(12):953-60
16825436
J Exp Med. 2007 Apr 16;204(4):853-63
17420270
Blood. 2002 Jan 1;99(1):61-6
11756153
Blood. 2002 Oct 15;100(8):2891-8
12351400
Blood. 2007 Sep 15;110(6):1906-15
17525286
Pediatrics. 2007 Sep;120(3):e622-8
17698967
Leukemia. 1996 Feb;10(2):197-203
8637226
J Pediatr. 1984 Apr;104(4):569-73
6368780
Br J Haematol. 2002 Oct;119(1):180-8
12358924
Blood. 2002 Oct 1;100(7):2367-73
12239144
Pediatr Blood Cancer. 2006 Apr;46(4):482-8
16365863
Am J Hum Genet. 2009 Oct;85(4):482-92
19804848
Science. 1999 Dec 3;286(5446):1957-9
10583959
Hum Mol Genet. 2005 Mar 15;14(6):827-34
15703195
Hematology Am Soc Hematol Educ Program. 2009;:127-31
20008190
Haematologica. 2010 Apr;95(4):538-41
20378576
Bone Marrow Transplant. 2008 Oct;42 Suppl 2:S47-50
18978744
Haematologica. 2008 Nov;93(11):1694-701
18768529